The first effective pill against chronic insomnia arrives: “It’s really new”
Neurologist Diego García-Borreguero is one of the experts who has studied the drug the most, the first therapeutic advance in Europe in 60 years.
On April 29, the European Medicines Agency (EMA) authorized a new active ingredient on the continent: a small triangular tablet that will be offered in two doses (25 and 50 milligrams) and that will still take some time – it is not known how long – to be in Spanish pharmacies. The molecule in question is called daridorexant and its approval would not be very important were it not for the fact that it is the first drug specifically indicated for insomnia lasting more than three months: a disorder that affects between 8 and 12% of the population Spanish. “In practice, it is usually chronic,” the international medical director of the Sleep Institute, neurologist Diego García-Borreguero, told EL ESPAÑOL.
